Drugs / DTaP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03165981 Background | Aug 2017 → Jan 2018 | — | Duke University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03165981 ↗ |
| Modality | Vaccine | “Children in the simultaneous group will receive PCV13, DTaP, and IIV vaccines at Visit 1” NCT03165981 ↗ |